Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Extension Study With REQUIP PR for Subjects From Study ROP111528

NCT01536574 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01536574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01536574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Extension Study With REQUIP PR for Subjects From Study ROP111528
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
September 2, 2010
Completion date
March 28, 2012
Enrollment
295 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease